McLaren Greater Lansing Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 19
• Cancer Immunotherapy and Biomarkers 8
• Hemoglobinopathies and Related Disorders 8
• COVID-19 Clinical Research Studies 5
• Chronic Lymphocytic Leukemia Research 4
• Lymphoma Diagnosis and Treatment 4
• Systemic Lupus Erythematosus Research 4
• Tuberculosis Research and Epidemiology 4
• Venous Thromboembolism Diagnosis and Management 4
• Viral-associated cancers and disorders 4
• Acute Myeloid Leukemia Research 3
• Breast Cancer Treatment Studies 3

Most cited

1. The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

   Nature communications · 2022 · 87 citations · Craig Cole

2. Exhaled breath biomarker sensing.

   Biosensors & bioelectronics · 2021 · 51 citations · Borys Hrinczenko

3. Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma.

   Blood · 2021 · 64 citations · Craig Cole

4. Addressing the disparities: the approach to the African American patient with multiple myeloma.

   Blood cancer journal · 2023 · 37 citations · Craig Cole

5. Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.

   Blood advances · 2025 · 11 citations · Craig Cole

6. Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations.

   The American journal of medicine · 2023 · 31 citations · Craig Cole

7. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel.